Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03649178 · ClinicalTrials.gov registry record · NA
Dietary Salt in Rheumatoid Arthritis
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03649178 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 18 participants.
The verdict
NCT03649178, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
In this study investigators propose to address the following hypotheses: 1) Reduction in dietary sodium will decrease inflammation in patients with rheumatoid arthritis (RA). 2) Reduction in dietary sodium will decrease blood pressure in patients with RA. 3) Reduction in dietary sodium will decrease tissue sodium in patients with RA.
Interventions
- OTHER salt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2020-01-02 |
| Est. Completion | 2024-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03649178
The ClinicalTrials.gov registry entry for NCT03649178 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which salt is the first listed.
NCT03649178 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03649178 about?
NCT03649178 is a clinical study titled "Dietary Salt in Rheumatoid Arthritis". In this study investigators propose to address the following hypotheses: 1) Reduction in dietary sodium will decrease inflammation in patients with rheumatoid arthritis (RA). 2) Reduction in dietary sodium will decrease blood pressure in patients with RA. 3) Reduction in dietary sodium will decrease...
What is the current status of trial NCT03649178?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2020-01-02. Estimated completion is 2024-12-30.
What interventions are being tested in trial NCT03649178?
The interventions under investigation include: salt (OTHER).
Who is sponsoring clinical trial NCT03649178?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.